<HashMap><database>biostudies-arrayexpress</database><scores/><additional><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><submitter>veronica manicardi</submitter><instrument_platform>NextSeq 500</instrument_platform><study_type>ChIP-seq</study_type><organism>Homo sapiens</organism><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-14152</full_dataset_link><description>The aim of the experiment was to explore the RUNX2 genomic functions in the papillary thyroid carcinoma. To this end, we performed Chromatin Immunoprecipitation followed by deep-sequencing using an antibody against RUNX2, RNA-Polymerase II and Histone Marks (H3K27ac, H3K4me1, H3K4me3) in MDA-T41  thyroid cancer cell line, in order to define the genomic regions bound by this transcription factor.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Sequencing - Sequencing was performed by Illumina Nextseq 500 instrument (High output kit v2, 1x75 cycles)</sample_protocol><sample_protocol>Growth Protocol - MDA-T41 cells were grown in RPMI-1640 supplemented with 1% non-essential amino acids, 10% FBS and 1% penicillin-streptomycin. All cell lines were grown at 37°C/ 5% CO2 and routinely tested for mycoplasma infection.</sample_protocol><sample_protocol>Library Construction - Libraries were obtained starting from 3ng of ChIP and Input samples following ThruPLEX DNA-Seq Kit (Takara Bio Ink) protocol.</sample_protocol><sample_protocol>Nucleic Acid Extraction - ChIP samples were purified with PCR Purification Kit (Qiagen) and eluted in 50ul of Elution Buffer.</sample_protocol><sample_protocol>Sample Collection - 20M cells were collected for Chromatin Immunoprecipitation.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><pubmed_authors>veronica manicardi</pubmed_authors></additional><is_claimable>false</is_claimable><name>ChIP-seq  against RUNX2, RNA-Polymerase II and Histone Marks (H3K27ac, H3K4me1, H3K4me3) in human Papillary Thyroid Cancer cell line (MDA-T41)</name><description>The aim of the experiment was to explore the RUNX2 genomic functions in the papillary thyroid carcinoma. To this end, we performed Chromatin Immunoprecipitation followed by deep-sequencing using an antibody against RUNX2, RNA-Polymerase II and Histone Marks (H3K27ac, H3K4me1, H3K4me3) in MDA-T41  thyroid cancer cell line, in order to define the genomic regions bound by this transcription factor.</description><dates><release>2025-12-31T00:00:00Z</release><modification>2025-12-31T02:02:13.684Z</modification><creation>2024-06-06T09:47:33.354Z</creation></dates><accession>E-MTAB-14152</accession><cross_references><ENA>ERP160916</ENA><Biostudies>E-MTAB-13777</Biostudies><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0003789</EFO><EFO>EFO_0002692</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>